We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.04T
AUM Growth
–
Cap. Flow
+$4.22T
Cap. Flow
% of AUM
104.32%
Top 10 Holdings %
Top 10 Hldgs %
32.57%
Holding
4,062
New
4,061
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$282B |
| 2 |
Apple
AAPL
|
+$248B |
| 3 |
Microsoft
MSFT
|
+$202B |
| 4 |
Amazon
AMZN
|
+$139B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$119B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.5% |
| 2 | Financials | 12.85% |
| 3 | Healthcare | 9.92% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
Relmada Therapeutics
RLMD
$384M
| $21.4M | ﹤0.01% |
+3,076,570
| New | +$14.6M |
2026 Q1
0 quarters
|
|
2302
Sana Biotechnology
SANA
$865M
| $21.4M | ﹤0.01% |
+7,434,724
| New | +$29.3M |
2026 Q1
0 quarters
|
|
2303
Ironwood Pharmaceuticals
IRWD
$601M
| $21.4M | ﹤0.01% |
+6,097,454
| New | +$25M |
2026 Q1
0 quarters
|
|
2304
Arrow Financial
AROW
$700M
| $21.4M | ﹤0.01% |
+637,527
| New | +$21.3M |
2026 Q1
0 quarters
|
|
2305
Hingham Institution for Saving
HIFS
$632M
| $21.4M | ﹤0.01% |
+74,718
| New | +$21.8M |
2026 Q1
0 quarters
|
|
|
NTSK
2306
Netskope Inc
NTSK
$7.25B
| $21.3M | ﹤0.01% |
+2,508,079
| New | +$31.1M |
2026 Q1
0 quarters
|
|
|
BAND
2307
Bandwidth Inc
BAND
$2.05B
| $21.3M | ﹤0.01% |
+1,194,878
| New | +$17.5M |
2026 Q1
0 quarters
|
|
2308
CorMedix
CRMD
$560M
| $21.3M | ﹤0.01% |
+3,129,656
| New | +$23.1M |
2026 Q1
0 quarters
|
|
2309
CEVA Inc
CEVA
$1.04B
| $21.2M | ﹤0.01% |
+1,133,499
| New | +$23.8M |
2026 Q1
0 quarters
|
|
2310
Cannae Holdings
CNNE
$674M
| $21.2M | ﹤0.01% |
+1,861,606
| New | +$25M |
2026 Q1
0 quarters
|
|
2311
Replimune Group
REPL
$1.23B
| $21.1M | ﹤0.01% |
+2,759,120
| New | +$21.1M |
2026 Q1
0 quarters
|
|
2312
Riley Exploration Permian
REPX
$935M
| $21.1M | ﹤0.01% |
+578,960
| New | +$17.2M |
2026 Q1
0 quarters
|
|
2313
Columbia Financial
CLBK
$3.08B
| $21M | ﹤0.01% |
+2,642,684
| New | +$20.7M |
2026 Q1
0 quarters
|
|
2314
Peoples Financial Services
PFIS
$694M
| $20.9M | ﹤0.01% |
+392,034
| New | +$20.7M |
2026 Q1
0 quarters
|
|
2315
iQIYI
IQ
$957M
| $20.9M | ﹤0.01% |
+15,465,141
| New | +$26.7M |
2026 Q1
0 quarters
|
|
|
CBLL
2316
CeriBell Inc
CBLL
$909M
| $20.8M | ﹤0.01% |
+1,137,132
| New | +$22.9M |
2026 Q1
0 quarters
|
|
|
NAVN
2317
Navan Inc
NAVN
$5.58B
| $20.8M | ﹤0.01% |
+1,574,053
| New | +$18.7M |
2026 Q1
0 quarters
|
|
2318
Mativ Holdings
MATV
$657M
| $20.8M | ﹤0.01% |
+2,393,983
| New | +$27.5M |
2026 Q1
0 quarters
|
|
|
NUTX
2319
Nutex Health
NUTX
$1.48B
| $20.8M | ﹤0.01% |
+219,131
| New | +$26.9M |
2026 Q1
0 quarters
|
|
2320
Cytek Biosciences
CTKB
$763M
| $20.8M | ﹤0.01% |
+4,762,904
| New | +$22.5M |
2026 Q1
0 quarters
|
|
2321
Phreesia
PHR
$625M
| $20.8M | ﹤0.01% |
+2,479,247
| New | +$32.8M |
2026 Q1
0 quarters
|
|
2322
Cooper-Standard Automotive
CPS
$388M
| $20.8M | ﹤0.01% |
+744,974
| New | +$24.9M |
2026 Q1
0 quarters
|
|
|
PSIX
2323
Power Solutions International
PSIX
$1.03B
| $20.8M | ﹤0.01% |
+340,974
| New | +$24.3M |
2026 Q1
0 quarters
|
|
|
DFTX
2324
Definium Therapeutics
DFTX
$5.03B
| $20.7M | ﹤0.01% |
+1,096,978
| New | +$18.6M |
2026 Q1
0 quarters
|
|
2325
Malibu Boats
MBUU
$453M
| $20.7M | ﹤0.01% |
+798,418
| New | +$23.8M |
2026 Q1
0 quarters
|
|
Similar funds
Vanguard Capital Management's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Capital Management, which disclosed 4,062 positions worth $4.04T. Its ten largest holdings account for 33% of the portfolio.
Its largest position is NVIDIA: 1,538,550,382 shares worth $268B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, followed by Financials and Healthcare.
- Vanguard Capital Management's largest Q1 2026 buy was NVIDIA: 1,538,550,382 shares worth $268B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.04T portfolio in Q1 2026.
- Vanguard Capital Management disclosed 4,062 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Capital Management's 13F filing for Q1 2026, filed 8 May 2026.